Top 5 Risers
|
| Stock |
Rating |
Analysis |
| DK |
BUY |
Many analysts are expecting higher than previously expected long term growth from Delek, and its near-term earnings outlook is also improving. |
| HOC |
STRONGBUY |
The long term projected growth rate for Holly is rising, and this is happenening at a time when historical earnings have already increased significantly. |
| UTHR |
BUY |
Projected value continues to rise for United Therapeutics while long term increases in earnings growth are also becoming more widely expected. |
| PWER |
BUY |
Projected value continues to rise for Power-One while long term increases in earnings growth are also becoming more widely expected. |
| PDA |
BUY |
Perdigao is gaining higher expectations and its recent history of its earnings increases is significant. |